TARGETED MOLECULAR DIAGNOSTICS
TARGETED MOLECULAR DIAGNOSTICS
Industry:
Clinical Trials Health Care Health Diagnostics Medical
Founded:
2004-01-01
Status:
Active
Contact:
(630)789-1233
Similar Organizations
Gema
Gema Diagnostics is a molecular diagnostics company.
Hype Medical
HYPE Medical is clinic management company
Portland Leadership Institute
Portland Leadership Institute is a Medical company.
Predicant Biosciences
cancer diagnostic startup using protein biomarker signatures in blood
The Banks Group LLC
The Banks Group LLC is a Clinical Trials company.
The Green Door
Largest Cannabis Dispensary in San Francisco
The Low T Center
Low Testosterone Diagnosis and Treatment Company
More informations about "Targeted Molecular Diagnostics"
Targeted Molecular Diagnostics - Crunchbase
Dec 1, 2008 Who are Targeted Molecular Diagnostics's competitors? Alternatives and possible competitors to Targeted Molecular Diagnostics may include The Low T Center, Gema, and Portland Leadership Institute.See details»
TARGETED MOLECULAR DIAGNOSTICS, LLC - NPI 1518959741
Aug 15, 2005 Is Organization Subpart? Establishments like Targeted Molecular Diagnostics, Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by …See details»
WHO launches new guidance on the use of targeted …
Mar 20, 2024 The World Health Organization (WHO) has just published recommendations on the use of a new class of diagnostic technologies: targeted next-generation sequencing (NGS) tests for the diagnosis of drug-resistant …See details»
Targeted Molecular Diagnostics - Crunchbase
This year, Targeted Molecular Diagnostics is projected to spend $14.4K on IT, according to Aberdeen.Targeted Molecular Diagnostics is a Clinical Trials company.See details»
Trop2-Targeted Molecular Imaging in Solid Tumors: Current …
Nov 13, 2024 Our review captures the latest progress in Trop2-targeted molecular imaging, focusing on both diagnostic and therapeutic applications across diverse tumor types, including …See details»
Targeted Molecular Diagnostics - PitchBook
Sep 8, 2011 Information on acquisition, funding, investors, and executives for Targeted Molecular Diagnostics. Use the PitchBook Platform to explore the full profile.See details»
Molecular diagnostic tools for the World Health Organization …
Jun 2, 2023 The main characteristics of the molecular methods are systematically discussed, followed by recommendations and information on available evidence levels for diagnostic …See details»
Use of targeted next-generation sequencingto detect …
Jul 23, 2023 A rapid communication released by the World Health Organization (WHO) Global Tuberculosis Programme announces upcoming updates to the guidance on the use of targeted next-generation sequencing for diagnosis of …See details»
TARGETED MOLECULAR DIAGNOSTICS, LLC - NPIdb.org
NPI Profile & details for TARGETED MOLECULAR DIAGNOSTICS, LLC ... 1 Some organization health care providers are made up of components that furnish different types of health care or …See details»
Implementing molecular tuberculosis diagnostic methods in …
Feb 14, 2023 The WHO emphasises the importance of DST before treatment initiation, using molecular WHO-recommended rapid diagnostic tests (mWRDs). Currently available mWRDs …See details»
Molecular Targeted Diagnostics Market Size & Forecast 2032
Apr 30, 2024 The Molecular Targeted Diagnostics Market is projected to witness substantial growth from USD 15,755.95 million in 2024 to USD 26,709.46 million by 2032, with a notable …See details»
Significance of molecular diagnostics for therapeutic decision …
May 12, 2023 Targeted therapies based on sequencing analysis of patients’ individual tumors improved survival of many cancer patients. Therefore, we retrospectively investigated whether …See details»
Leading Medical Organizations Update Guideline for Molecular
Jan 22, 2018 The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,300+ …See details»
Pyrazinamide-resistant Tuberculosis Obscured From Common …
May 1, 2023 This risk of targeted approaches identifying small susceptible subpopulations while obscuring the predominant, resistant population in the sample applies to molecular resistance …See details»
Molecular diagnostics | Nature Reviews Drug Discovery
Molecular diagnostics are increasingly being developed to help guide treatment choice of targeted therapies, as well as to help optimize treatment outcomes and reduce the risk of serious …See details»
In silico evaluation of WHO-endorsed molecular methods to
Oct 22, 2022 PCR-based molecular diagnostic tests have been instrumental in increasing DST globally and several assays have now been endorsed by the World Health Organization …See details»
Molecular diagnostics enables detection of actionable targets: the ...
Feb 1, 2023 Molecular diagnostics refining diagnoses and detecting actionable targets can inform on possible targeted mechanism-of-action-based treatments for these patients, …See details»
Targeted next-generation sequencing: a Swiss army knife for ...
Mar 1, 2021 Thus, current molecular PZA susceptibility diagnostics (targeted Sanger sequencing), a Line Probe Assay (LPA) recently endorsed by the WHO (World Health …See details»
Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the …
Nov 1, 2022 The World Health Organization (WHO) recently revised its guidelines for rapid diagnosis of drug-resistant tuberculosis (TB). This study aimed to investigate if TB reference …See details»
Companion Diagnostics Market to grow by USD 28.98 Billion …
6 days ago /PRNewswire/ -- Report on how AI is driving market transformation - The global companion diagnostics market size is estimated to grow by USD 28.98 billion from...See details»